Department of Surgery, Division of Cardiac Surgery, University of Verona, Verona, Italy.
Resuscitation. 2013 Feb;84(2):244-8. doi: 10.1016/j.resuscitation.2012.06.016. Epub 2012 Jul 5.
To compare the effect of δ-opioid receptor agonist, d-Ala2-d-Leu5 enkephalin (DADLE) with normothermic control and therapeutic hypothermia on post resuscitation myocardial function in a model of extracorporeal life support (ECLS).
Ventricular fibrillation (VF) was induced in male Wistar rats. After 10 min of untreated VF, venoarterial ECLS was instituted for 60 min. At the beginning of ECLS animals were randomized to three groups of ten: normothermia, hypothermia (32 °C) and DADLE intravenous infusion (1 mg/kg/h). Cooling to 32 °C or normothermia or drug infusion lasted for the entire ECLS. Plasma samples and myocardial biopsies were obtained and left-ventricular (LV) function was assessed by a conductance catheter at baseline and after weaning from ECLS.
DADLE administration resulted in a significantly enhanced recovery of LV systolic function expressed by slope of the LV end-systolic pressure volume relationship (Ees) and preload recruitable stroke work (PRSW) than hypothermia and normothermia. LV stiffness indicated by end-diastolic pressure volume relationship (EDPVR) was significantly lower after DADLE administration (P<0.01). LV relaxation described by Tau was preserved after DADLE treatment but not after normothermia or mild hypothermia (P<0.01). Plasma lactate concentrations were lower in DADLE group (P<0.05). DADLE and not conventional hypothermia significantly increased phosphorylation of the kinases ERK1 and 2 (3.9±0.3 and 3.1±0.5 vs. 0.4±0.1 and 0.3±0.1-fold of baseline levels) (P<0.001). Both DADLE and hypothermia but not normothermia increase phosphorylation of Akt.
DADLE was more effective than mild therapeutic hypothermia in recovering myocardial function and activation of the pro-survival kinases Akt and ERK after ECLS.
比较 δ-阿片受体激动剂,D-丙氨酰-D-亮氨酸脑啡肽(DADLE)与常温控制和治疗性低温对体外生命支持(ECLS)后再灌注心肌功能的影响。
雄性 Wistar 大鼠诱导心室颤动(VF)。在未经治疗的 VF 10 分钟后,进行静脉-动脉 ECLS 60 分钟。在 ECLS 开始时,动物随机分为三组,每组 10 只:常温、低温(32°C)和静脉内 DADLE 输注(1mg/kg/h)。冷却至 32°C 或常温或药物输注持续整个 ECLS。在基线和从 ECLS 脱机后,通过导纳导管获得血浆样本和心肌活检,并评估左心室(LV)功能。
与低温和常温相比,DADLE 给药可显著增强 LV 收缩功能的恢复,表现为 LV 收缩末期压力-容积关系(Ees)斜率和预负荷可膨胀功(PRSW)的增加。DADLE 给药后 LV 僵硬度(由舒张末期压力-容积关系(EDPVR)表示)显著降低(P<0.01)。DADLE 治疗后 LV 松弛(由 Tau 描述)得到保留,但常温或轻度低温后则不然(P<0.01)。DADLE 组血浆乳酸浓度较低(P<0.05)。DADLE 而非常规低温显著增加 ERK1 和 2 的激酶磷酸化(3.9±0.3 和 3.1±0.5 与基线水平的 0.4±0.1 和 0.3±0.1 倍)(P<0.001)。DADLE 和低温均可增加 Akt 的磷酸化,但常温则不行。
与轻度治疗性低温相比,DADLE 在 ECLS 后恢复心肌功能和激活生存相关激酶 Akt 和 ERK 方面更有效。